In silico identification and biological evaluation of a selective MAP4K4 inhibitor against pancreatic cancer
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Enzyme Inhibition and Medicinal Chemistry"
DOI: 10.1080/14756366.2023.2166039
Abstract: Abstract Inhibiting a specific target in cancer cells and reducing unwanted side effects has become a promising strategy in pancreatic cancer treatment. MAP4K4 is associated with pancreatic cancer development and correlates with poor clinical outcomes.… read more here.
Keywords: f389 0746; selective map4k4; pancreatic cancer; map4k4 ... See more keywords